Скачать или смотреть Shaily Engineering Plastics share latest news | Today's news | From IKEA to Big Pharma

In this video, we deep dive into Shaily Engineering Plastics – a company that started with just 2 injection molding machines and has now become one of India’s largest exporters of precision plastic components. With a 70% market share in Semaglutide pens (GLP-1 pens) and strong partnerships with global giants like IKEA and leading pharma companies, Shaily is positioning itself as a key player in the healthcare and consumer segments.

We will cover:

✅ Company Overview & History

✅ Core Business & Key Products

✅ Global Presence & Clients

✅ Segment-Wise Financial Performance (Consumer, Healthcare, Industrial)

✅ Capacity Expansion Plans (75 Million Pens Target)

✅ Product & Market Insights (Semaglutide, Neo & Harmony Platforms, New Products)

✅ Key Risks & Challenges (Execution, Litigation, Macroeconomic)

✅ Shareholding Pattern & Investor Data

Key Highlights

181% YoY growth in Healthcare revenue

75% of revenue from exports (40+ countries)

Strong promoter holding (43.72%) with increasing institutional interest

Strategic focus on next-gen drug delivery devices & connected solutions

⚠️ Disclaimer

This video is created only for educational purposes. It does not constitute investment advice. The stock market is subject to risks, and viewers should consult their financial advisor before making any investment decisions.Hashtags

#ShailyEngineeringPlastics #MultibaggerStocks #StockAnalysis #PharmaGrowth #HealthcareStocks #Semaglutide #IndianStocks #Investing